Odonate Therapeutics, Inc. (ODTC)

Odonate Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Market Capitalization	21	0	1	6	10
Market Cap Growth	84347.79%	-95.03%	-91.89%	-35.76%	185.27%
Enterprise Value	-16	-8	-64	-146	-169
PE Ratio	2.93	0.00	-0.01	-0.05	-0.09
PB Ratio	0.20	0.00	0.01	0.05	0.06
P/FCF Ratio	2.46	0.01	-0.01	-0.06	-0.10
P/OCF Ratio	2.46	0.01	-0.01	-0.06	-0.10
EV/EBITDA Ratio	19.80	2.22	1.39	1.15	1.47
EV/EBIT Ratio	19.29	2.02	1.36	1.14	1.47
EV/FCF Ratio	-1.80	-4.42	0.84	1.28	1.74
Debt / Equity Ratio	0.00	0.00	0.01	0.04	0.01
Debt / EBITDA Ratio	-2.89	-0.77	-0.10	-0.04	-0.02
Debt / FCF Ratio	0.26	1.54	-0.06	-0.05	-0.02
Quick Ratio	111.58	82.54	4.73	5.81	7.28
Current Ratio	111.72	82.66	4.75	5.91	7.42
Return on Equity (ROE)	6.77%	42.58%	-115.27%	-92.81%	-66.99%
Return on Assets (ROA)	6.63%	41.40%	-86.48%	-75.26%	-57.58%
Return on Capital (ROIC)	-0.57%	-16.85%	-73.24%	-90.08%	-69.92%
Earnings Yield	34.09%	168769.81%	-13343.98%	-2002.50%	-1106.91%
FCF Yield	40.68%	7055.00%	-14796.45%	-1799.83%	-985.59%
Buyback Yield / Dilution	-98440.07%	96.16%	-15.40%	-8.57%	-23.78%
Total Shareholder Return	-98440.07%	96.16%	-15.40%	-8.57%	-23.78%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.